Results 181 to 190 of about 323,328 (291)
Yellow fever mortality in Brazil: an age-period-cohort study. [PDF]
Lopes LCP.
europepmc +1 more source
Attractive toxic sugar bait containing ivermectin (ATSB‐IVM) ingestion markedly reduced blood feeding, survival, oviposition, egg production and larval hatching, with the strongest effects when baits were ingested before blood feeding. Timing of ingestion (48–96 h before or after blood feeding) shaped sublethal impacts across the first and second ...
Thais Alves de Moura +2 more
wiley +1 more source
A framework to assess the risk of yellow fever emergence. [PDF]
Perlant C +8 more
europepmc +1 more source
The Role of the Mylohyoid Line in the Spread of Mandibular Odontogenic Deep Neck Infection
ABSTRACT Introduction Although mandibular odontogenic deep neck infections are occasionally fatal, the transmission pathway has not been elucidated. Materials and Methods This multicenter retrospective study was comprised of the patients of both sexes who were over 18 years of age and who had mandibular odontogenic deep neck abscesses.
Eiji Iwata +14 more
wiley +1 more source
Pickpocket315 affects male mating behavior in the yellow fever mosquito Aedes aegypti. [PDF]
Wyer CAS +7 more
europepmc +1 more source
Fatal Chronic Varicella‐Zoster Viral Infection in a Young Man With Chediak–Higashi Syndrome
ABSTRACT Chediak–Higashi syndrome (CHS) is a rare autosomal recessive primary immunodeficiency characterized by partial oculocutaneous albinism, neurologic involvement, and a predisposition to severe infections. Patients are particularly susceptible to developing hemophagocytic lymphohistiocytosis (HLH), which significantly worsens prognosis. We report
Albane Badet +4 more
wiley +1 more source
Beyond dengue and Oropouche: The urgent need for yellow fever preparedness in Cuba. [PDF]
Cañete R +2 more
europepmc +1 more source
ABSTRACT Background INTEGUMENT‐PED/NCT04845620, a 4‐week, phase 3 trial, demonstrated efficacy and safety of roflumilast cream 0.05% in children aged 2–5 years with mild‐to‐moderate atopic dermatitis (AD). A phase 3 open‐label extension trial (INTEGUMENT‐OLE [NCT04804605]) investigated long‐term outcomes continuing roflumilast cream for ≤ 56 weeks ...
Lawrence F. Eichenfield +14 more
wiley +1 more source
Yellow fever beyond the Amazon: surveillance challenges and the role of <i>Callithrix</i> spp. in sylvatic cycles in Brazil. [PDF]
Drumond BP, Nogueira ML, Vasilakis N.
europepmc +1 more source

